Google
VCYT 株価分析 — VERACYTE INC (Healthcare >> Diagnostics & Research)
VCYT に関するよくある質問
VCYTのPER（株価収益率）は？
VERACYTE INC（VCYT）は現在PER 41.67倍で取引されています。
VCYTのROE（自己資本利益率）は？
VERACYTE INCのROEは8.25%です。
VCYTの配当利回りは？
VERACYTE INCの配当利回りは0.00%です。
VCYTの品質スコア（Quality Score）は？
当社のAIはVCYTの総合財務品質を100点中77点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
VCYTは今が買い時ですか？
当社AIのタイミングスコアは100点中69点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
VCYTはどのセクターに属しますか？
VERACYTE INCはHealthcare >> Diagnostics & Researchセクターに分類されます（NASDAQ市場）
VCYT AI Analysis Summary
Our AI summary for VCYT: VERACYTE INC (NASDAQ), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 41.67, ROE of 8.25%, a dividend yield of 0.00%. Its financial Quality Score stands at 77/100 — mid-range fundamentals relative to the market. The AI Timing Score is 69/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 46.32
Price
-13.46
(-22.52%)
Day Change
|
|
|---|
VCYT, ファンダメンタルスコアはgood ( ファンダメンタル = 77) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROEが低い
平均ROEが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
2304
|
| Magic Formula Rank by ROE |
2304
|
| Magic Formula Rank by ROIC |
2627
|
| Price | 46.32 |
| PBV / Sector |
3.44 / -29.69
|
| Earning Per Share | 1.11 |
| PE / Sector |
41.67 / 48.18
|
| PEG or PE/Growth / Sector |
0.91 / 1.64
|
| Average 1M Daily Value |
66.44 M
|
| Average 1W Daily Value |
99.47 M
|
| Timing Factors |
|
57% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
68% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:39 |
| Symbol | VCYT |
| Name | VERACYTE INC |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 79.79 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 4,770.00 / 38,081.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6000 Shoreline Court, South San Francisco, CA, United States, 94080
Phone: 650 243 6300
Website: https://www.veracyte.com
Employees: 755
Description: Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
